arrow
T

Tindara Franchina

University of Messina
H指数:23
被引数:2,165

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Feasibility and safety of recombinant zoster vaccination in patients undergoing active cancer treatments: A real-world single-center experience

重组带状疱疹疫苗在正在接受积极癌症治疗患者中的可行性与安全性:一项真实世界单中心经验

2026-07-300
OA
A Silent Saboteur of Immunotherapy: Antibiotic Use and Its Impact on Immune Checkpoint Inhibitors Efficacy, a Systematic Review and Meta-Analysis of Recent Studies

免疫疗法的一个无声破坏者:抗生素使用及其对免疫检查点抑制剂疗效的影响,一项近期研究的系统评价和荟萃分析

Cancers
IF4.4
2026-03-080
OAAI
Late endocrine-metabolic complications in survivors of young adult and adult-onset cancers: comprehensive evaluation and strategies for management. An Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical review

年轻成年及成年发病癌症幸存者的晚期内分泌-代谢并发症:全面评估与管理策略。意大利医学肿瘤学会(AIOM)、意大利医学糖尿病学会(AMD)、意大利糖尿病学会(SID)、意大利内分泌学会(SIE)、意大利药理学学会(SIF)多学科批判性综述

2025-12-030
OAAI
Fusobacterium Nucleatum in Colorectal Cancer: Relationship Among Immune Modulation, Potential Biomarkers and Therapeutic Implications

梭杆菌属核梭杆菌在结直肠癌中的作用:免疫调节、潜在生物标志物及治疗意义之间的关系

2025-10-060
OAAI
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies

实体肿瘤和糖尿病患者疫苗接种:现有证据与建议。一份来自多学科科学学会专家组的立场声明

2025-04-230
OA
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view
2024-06-276
OAAI
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group
2024-05-010
OAAI
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper

癌症患者的糖尿病管理。意大利医学肿瘤学协会,意大利医学糖尿病学家协会,意大利糖尿病学会,意大利内分泌学会和意大利药理学学会多学科共识立场文件

2023-12-017
OAAI
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view

MiRNA失调是2型糖尿病和癌症发展的共同途径的基础: 意大利医学肿瘤学协会 (AIOM)/意大利医学糖尿病学家协会 (AMD)/意大利糖尿病学会 (SID)/意大利内分泌学会 (SIE)/意大利药理学会 (SIF) 多学科批判性观点

2023-06-0114
OAAI
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper

肿瘤学中的皮质类固醇: 使用,过度使用,适应症,禁忌症。意大利医学肿瘤学协会 (AIOM)/意大利医学糖尿病学家协会 (AMD)/意大利内分泌学会 (SIE)/意大利药理学学会 (SIF) 多学科共识立场文件

2022-12-0114
OAAI